Donoghoe Nicholas (CIK 1762951) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Sell ABBV (12,874 shares), Buy ABBV (13,031 shares), Buy ABBV (4,632 shares), Buy ABBV (5,172 shares), Buy ABBV (6,222 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Sell | 12,874 | $3.0M |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Buy | 13,031 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Buy | 4,632 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Buy | 5,172 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Buy | 6,222 | $0 |
| 2025-08-07 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Sell | 3,234 | $641,239 |
| 2025-08-07 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Sell | 10,061 | $2.0M |
| 2025-03-04 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Sell | 11,230 | $2.3M |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Buy | 11,017 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Buy | 4,520 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Buy | 4,634 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | Buy | 5,174 | $0 |
Source: SEC Form 4 filings · as of 2026-03-03